학술논문
Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non–Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials
Document Type
Review Article
Author
Source
In Clinical Lung Cancer May 2015 16(3):173-182
Subject
Language
ISSN
1525-7304